Cargando…
Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV
Genotype V (GV) Japanese encephalitis virus (JEV) has emerged in Korea and China since 2009. Recent findings suggest that current Japanese encephalitis (JE) vaccines may reduce the ability to induce neutralizing antibodies against GV JEV compared to other genotypes. This study sought to produce a no...
Autores principales: | Tajima, Shigeru, Taniguchi, Satoshi, Nakayama, Eri, Maeki, Takahiro, Inagaki, Takuya, Saijo, Masayuki, Lim, Chang Kweng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538582/ https://www.ncbi.nlm.nih.gov/pubmed/34696184 http://dx.doi.org/10.3390/vaccines9101077 |
Ejemplares similares
-
Amino Acid at Position 166 of NS2A in Japanese Encephalitis Virus (JEV) Is Associated with In Vitro Growth Characteristics of JEV
por: Tajima, Shigeru, et al.
Publicado: (2020) -
E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice
por: Tajima, Shigeru, et al.
Publicado: (2019) -
Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus
por: Saga, Ryohei, et al.
Publicado: (2016) -
Insights into the evolutionary history of Japanese encephalitis virus (JEV) based on whole-genome sequences comprising the five genotypes
por: Gao, Xiaoyan, et al.
Publicado: (2015) -
Genotype Change in Circulating JEV Strains in Fujian Province, China
por: Dong, Nihua, et al.
Publicado: (2023)